Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.04
Market Cap
$31.0M
Price Target
Refer to Report
Volume
219.3K
52wk Range
$0.87 - $22.22
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.